1. Home
  2. STEC vs INKT Comparison

STEC vs INKT Comparison

Compare STEC & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STEC
  • INKT
  • Stock Information
  • Founded
  • STEC 2006
  • INKT 2017
  • Country
  • STEC China
  • INKT United States
  • Employees
  • STEC N/A
  • INKT N/A
  • Industry
  • STEC
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • STEC
  • INKT Health Care
  • Exchange
  • STEC NYSE
  • INKT Nasdaq
  • Market Cap
  • STEC 31.4M
  • INKT 28.5M
  • IPO Year
  • STEC 2021
  • INKT 2021
  • Fundamental
  • Price
  • STEC $0.73
  • INKT $0.46
  • Analyst Decision
  • STEC
  • INKT Strong Buy
  • Analyst Count
  • STEC 0
  • INKT 2
  • Target Price
  • STEC N/A
  • INKT $6.50
  • AVG Volume (30 Days)
  • STEC 288.3K
  • INKT 43.7K
  • Earning Date
  • STEC 12-31-2024
  • INKT 11-14-2024
  • Dividend Yield
  • STEC N/A
  • INKT N/A
  • EPS Growth
  • STEC N/A
  • INKT N/A
  • EPS
  • STEC N/A
  • INKT N/A
  • Revenue
  • STEC $260,474,693.00
  • INKT N/A
  • Revenue This Year
  • STEC $9.76
  • INKT N/A
  • Revenue Next Year
  • STEC $15.85
  • INKT N/A
  • P/E Ratio
  • STEC N/A
  • INKT N/A
  • Revenue Growth
  • STEC N/A
  • INKT N/A
  • 52 Week Low
  • STEC $0.20
  • INKT $0.46
  • 52 Week High
  • STEC $3.25
  • INKT $1.90
  • Technical
  • Relative Strength Index (RSI)
  • STEC 41.44
  • INKT 15.27
  • Support Level
  • STEC $0.72
  • INKT $0.64
  • Resistance Level
  • STEC $0.84
  • INKT $0.67
  • Average True Range (ATR)
  • STEC 0.11
  • INKT 0.06
  • MACD
  • STEC -0.01
  • INKT -0.02
  • Stochastic Oscillator
  • STEC 29.76
  • INKT 0.00

About STEC SANTECH HOLDINGS LIMITED

Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: